S Bryan

Author PubWeight™ 63.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007 3.30
2 A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess 2006 2.54
3 A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005 2.42
4 Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis. BMJ 2005 2.41
5 EQ-5D in patients with dementia: an investigation of inter-rater agreement. Med Care 2001 2.06
6 Treatment of natal cleft sinus: a prospective clinical and economic evaluation. BMJ 1992 1.82
7 Mammography screening: an incremental cost effectiveness analysis of double versus single reading of mammograms. BMJ 1996 1.70
8 The use of economic evaluations in NHS decision-making: a review and empirical investigation. Health Technol Assess 2008 1.57
9 Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. Health Technol Assess 2002 1.48
10 Riluzole for motor neurone disease. More trials are needed. BMJ 2001 1.47
11 Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2008 1.43
12 Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour. BJOG 2010 1.41
13 Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Health Technol Assess 2009 1.38
14 The effect of a picture archiving and communications system (PACS) on diagnostic performance in the accident and emergency department. J Accid Emerg Med 2000 1.31
15 Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technol Assess 2010 1.26
16 Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol 1989 1.16
17 Is Mycobacterium bovis in the environment important for the persistence of bovine tuberculosis? Biol Lett 2006 1.16
18 The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health Technol Assess 2004 1.14
19 The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review. Health Technol Assess 2001 1.13
20 A comparison of image reject rates when using film, hard copy computed radiography and soft copy images on picture archiving and communication systems (PACS) workstations. Br J Radiol 1999 1.10
21 An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. Br J Obstet Gynaecol 1993 1.09
22 Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling. Sex Transm Infect 2006 1.07
23 Humoral immunity to commensal oral bacteria in human infants: salivary secretory immunoglobulin A antibodies reactive with Streptococcus mitis biovar 1, Streptococcus oralis, Streptococcus mutans, and Enterococcus faecalis during the first two years of life. Infect Immun 1999 1.06
24 Policy dilemmas for oral anticoagulation management. Br J Gen Pract 2000 1.02
25 The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess 2002 1.00
26 An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost 2008 1.00
27 Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK. Health Technol Assess 2005 0.99
28 The correct approach to modelling and evaluating chlamydia screening. Sex Transm Infect 2004 0.97
29 A brief pain management program compared with physical therapy for low back pain: results from an economic analysis alongside a randomized clinical trial. Arthritis Rheum 2007 0.96
30 A review of preference-based health-related quality of life questionnaires in spinal cord injury research. Spinal Cord 2012 0.95
31 Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer. Lung Cancer 2002 0.91
32 The impact of a picture archiving and communication system (PACS) upon an intensive care unit. Eur J Radiol 2000 0.91
33 Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technol Assess 2009 0.91
34 Management of orbital emphysema. Eye (Lond) 1998 0.91
35 Examining the influence of picture archiving communication systems and other factors upon the length of stay for patients with total hip and total knee replacements. Int J Technol Assess Health Care 1999 0.91
36 The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review. Health Technol Assess 2006 0.90
37 The clinical effectiveness and cost-effectiveness of routine dental checks: a systematic review and economic evaluation. Health Technol Assess 2003 0.90
38 Simultaneous bilateral posterior dislocation of shoulder. Am J Emerg Med 2002 0.88
39 Deadenylation of alpha 1-acid glycoprotein mRNA in cultured hepatic cells during stimulation by dexamethasone. J Biol Chem 1989 0.87
40 Predictors of patients' preferences for treatments to prevent heart disease. Heart 2006 0.84
41 The use of hyaluronan and its sulphated derivative patterned with micrometric scale on glass substrate in melanocyte cell behaviour. Biomaterials 2003 0.84
42 Evaluation of diffuse technologies: the case of digital imaging networks. Health Policy 1995 0.84
43 Patient costs in anticoagulation management: a comparison of primary and secondary care. Br J Gen Pract 2001 0.84
44 Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson's disease: the PD OT trial. J Neurol Neurosurg Psychiatry 2008 0.81
45 Humoral immunity to commensal oral bacteria in human infants: salivary antibodies reactive with Actinomyces naeslundii genospecies 1 and 2 during colonization. Infect Immun 1998 0.81
46 Clinicians' preferences for treatments to prevent coronary heart disease: a postal survey. Heart 2005 0.81
47 Primary care consultations and costs among HIV-positive individuals in UK primary care 1995-2005: a cohort study. Sex Transm Infect 2009 0.80
48 Factors influencing clinicians' decisions to prescribe medication to prevent coronary heart disease. J Clin Pharm Ther 2005 0.80
49 The cost-effectiveness of computer-assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study. J Thromb Haemost 2009 0.78
50 Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. Health Technol Assess 2002 0.78
51 Mitoxantrone in malignant lymphoma. Invest New Drugs 1985 0.77
52 Comparison of doses for bedside examinations of the chest with conventional screen-film and computed radiography: results of a randomized controlled trial. Radiology 2000 0.77
53 Studies on two novel angiotensin II actions. Clin Exp Hypertens A 1982 0.77
54 Complications of pregnancy in infertile couples: routine treatment versus assisted reproduction. Obstet Gynecol 1990 0.76
55 Variations in the incidence, management and outcome of stroke in residents under the age of 75 in two health districts of southern England. J Public Health Med 1995 0.76
56 Population screening for abdominal aortic aneurysm. J Public Health Med 1994 0.75
57 A process-based model for the partitioning of soluble, suspended particulate and bed sediment fractions of plutonium and caesium in the eastern Irish Sea. J Environ Radioact 2007 0.75
58 A comparison of the time required by radiologists for the preparation of clinico-radiological meetings when film and PACS are used. Eur Radiol 2000 0.75
59 Effect of oral contraceptives on rhythmic urinary metal excretion. Am J Obstet Gynecol 1976 0.75
60 The effect of a picture archiving and communication system (PACS) on patient radiation doses for examination of the lateral lumbar spine. Br J Radiol 1999 0.75
61 Infliximab for the treatment of ulcerative colitis. Health Technol Assess 2009 0.75
62 Commentary on my participation in an information campaign to Congress, March 5, 1979. Weather Vane 1979 0.75
63 A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancer. Invest New Drugs 1985 0.75
64 Piercings: Grossly swollen tongue. Br Dent J 2014 0.75
65 Computer integration: a challenge for dental assisting education. Dent Assist 1992 0.75
66 The effect of PACS on the visualization of the lateral cervical spine and the management of patients presenting with trauma. Med Inform (Lond) 1998 0.75
67 Nursing care of a child with meningococcemia. J Pediatr Nurs 1993 0.75
68 Clinical economics review: cost-effectiveness in the therapy of liver disease. Aliment Pharmacol Ther 1997 0.75
69 The mRNA for alpha 1-acid glycoprotein is deadenylated during stimulation by dexamethasone. Prog Clin Biol Res 1989 0.75
70 Charging into confusion. Health Serv J 1989 0.75
71 The 1997 NASN research award winner. School nurses' perceptions of their interactions with nurse practitioners. J Sch Nurs 1998 0.75
72 Clonazepam in the treatment of bipolar disorder in patients with non-lithium-induced renal insufficiency. J Clin Psychiatry 1987 0.75
73 Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation. Health Technol Assess 2002 0.75
74 Evidentiary examination in sexual assault. J Emerg Nurs 1989 0.75